Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes

Documenti analoghi

• Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials
  di: Paschalis Karakasis, et al.
  Pubblicazione: (2024)
• Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
  di: Scott A. Coon, et al.
  Pubblicazione: (2025)
• Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes
  di: Thomas Nyström, et al.
  Pubblicazione: (2024)
• Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population
  di: Adam Buckley, et al.
  Pubblicazione: (2024)
• Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
  di: Michael S. Kelly, et al.
  Pubblicazione: (2024)